Janux Therapeutics Inc (JANX)
52.00
-3.37
(-6.09%)
USD |
NASDAQ |
May 09, 16:00
51.96
-0.04
(-0.08%)
After-Hours: 20:00
Janux Therapeutics Shareholders Equity (Quarterly): 344.35M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 344.35M |
September 30, 2023 | 348.95M |
June 30, 2023 | 299.47M |
March 31, 2023 | 311.26M |
December 31, 2022 | 320.74M |
September 30, 2022 | 331.51M |
June 30, 2022 | 343.81M |
Date | Value |
---|---|
March 31, 2022 | 356.08M |
December 31, 2021 | 366.33M |
September 30, 2021 | 376.75M |
June 30, 2021 | 384.80M |
March 31, 2021 | -16.77M |
December 31, 2020 | -14.64M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-16.77M
Minimum
Mar 2021
384.80M
Maximum
Jun 2021
288.66M
Average
343.81M
Median
Jun 2022
Shareholders Equity (Quarterly) Benchmarks
Viking Therapeutics Inc | 933.89M |
Equillium Inc | 22.57M |
Minerva Neurosciences Inc | -36.59M |
Arvinas Inc | 609.70M |
Calidi Biotherapeutics Inc | -8.235M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 380.41M |
Total Liabilities (Quarterly) | 36.06M |
Current Ratio | 26.80 |